Arrowhead Pharmaceuticals Inc Strategic Asset Allocation Index
Arrowhead Pharmaceuticals Inc strategic asset allocation index. Arrowhead Pharmaceuticals Inc (ARWR) has a Strategic Asset Allocation Index of 116.9% as of September 2023. Strategic assets (PP&E of $335.56 Million plus long-term investments of $0.00) total $335.56 Million, measured against net assets of $287.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Arrowhead Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Arrowhead Pharmaceuticals Inc (2003–2023)
Strategic asset allocation index of Arrowhead Pharmaceuticals Inc from 2003 to 2023. This chart shows how Arrowhead Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 21 annual periods from 2003 to 2023. As of September 2023, the index stands at 116.9%, representing strategic assets of $335.56 Million against net assets of $287.16 Million USD. Check Arrowhead Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Arrowhead Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2003–2023)
Arrowhead Pharmaceuticals Inc strategic asset allocation index by year from 2003 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Arrowhead Pharmaceuticals Inc from 2003 to 2023, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ARWR company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 218.8% | $628.29 Million | $335.56 Million | $292.74 Million | $287.16 Million | ▲ +167.1 pp |
| 2022 | 51.7% | $216.17 Million | $110.30 Million | $105.87 Million | $418.34 Million | ▼ -20.3 pp |
| 2021 | 72.0% | $294.27 Million | $48.67 Million | $245.59 Million | $408.82 Million | ▲ +35.5 pp |
| 2020 | 36.5% | $168.37 Million | $30.88 Million | $137.49 Million | $461.78 Million | ▲ +8.8 pp |
| 2019 | 27.6% | $67.39 Million | $23.21 Million | $44.18 Million | $244.04 Million | ▲ +13.0 pp |
| 2018 | 14.6% | $13.94 Million | $13.94 Million | $- | $95.24 Million | ▼ -4.6 pp |
| 2017 | 19.2% | $15.51 Million | $15.51 Million | $- | $80.87 Million | ▲ +3.0 pp |
| 2016 | 16.2% | $15.39 Million | $15.39 Million | $- | $95.02 Million | ▲ +12.1 pp |
| 2015 | 4.1% | $4.53 Million | $4.53 Million | $- | $109.62 Million | ▼ -12.1 pp |
| 2014 | 16.2% | $26.96 Million | $3.87 Million | $23.09 Million | $165.99 Million | ▲ +2.6 pp |
| 2013 | 13.7% | $3.51 Million | $3.51 Million | $- | $25.73 Million | ▼ -41.9 pp |
| 2012 | 55.6% | $4.90 Million | $4.90 Million | $- | $8.81 Million | ▲ +55.4 pp |
| 2011 | 0.2% | $25.44K | $25.44K | $- | $12.56 Million | ▼ -1.5 pp |
| 2010 | 1.7% | $141.00K | $141.00K | $- | $8.08 Million | ▼ -9.1 pp |
| 2009 | 10.8% | $527.00K | $527.00K | $- | $4.86 Million | ▲ +0.7 pp |
| 2008 | 10.1% | $1.25 Million | $1.25 Million | $- | $12.30 Million | ▲ +4.7 pp |
| 2007 | 5.4% | $1.44 Million | $1.44 Million | $- | $26.46 Million | ▲ +1.4 pp |
| 2006 | 4.0% | $1.27 Million | $1.27 Million | $- | $31.61 Million | ▲ +0.2 pp |
| 2005 | 3.8% | $1.08 Million | $1.08 Million | $- | $28.02 Million | ▼ -4.0 pp |
| 2004 | 7.9% | $882.00K | $882.00K | $- | $11.23 Million | ▲ +7.7 pp |
| 2003 | 0.1% | $2.00K | $2.00K | $- | $1.42 Million | — |